| scholarly article | Q13442814 |
| P50 | author | Stephan Ripke | Q56959255 |
| Christina M. Hultman | Q65824971 | ||
| Pamela Sklar | Q17386505 | ||
| Danielle Posthuma | Q21257977 | ||
| Patrick F. Sullivan | Q56249782 | ||
| P2093 | author name string | August B Smit | |
| Mark H G Verheijen | |||
| Christiaan de Leeuw | |||
| Andrea Goudriaan | |||
| P2860 | cites work | Recurrence risks for schizophrenia in a Swedish National Cohort | Q57697471 |
| Therapy of Pelizaeus-Merzbacher disease in mice by feeding a cholesterol-enriched diet | Q57986020 | ||
| A Rho-related GTPase is involved in Ca(2+)-dependent neurotransmitter exocytosis | Q73538373 | ||
| Granulocyte-macrophage colony-stimulating factor induces an expression program in neonatal microglia that primes them for antigen presentation | Q74650434 | ||
| Global expression-profiling studies and oligodendrocyte dysfunction in schizophrenia and bipolar disorder | Q78756888 | ||
| Guilt beyond a reasonable doubt | Q80540702 | ||
| Rethinking schizophrenia | Q22251086 | ||
| Brain receptors for antipsychotic drugs and dopamine: direct binding assays | Q24619577 | ||
| Hundreds of variants clustered in genomic loci and biological pathways affect human height | Q24630979 | ||
| PLINK: a tool set for whole-genome association and population-based linkage analyses | Q24677407 | ||
| WebGestalt: an integrated system for exploring gene sets in various biological contexts | Q24813284 | ||
| Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
| Genome-wide association study identifies five new schizophrenia loci | Q28248384 | ||
| Common polygenic variation contributes to risk of schizophrenia and bipolar disorder | Q28250609 | ||
| Local regulation of fat metabolism in peripheral nerves | Q28510849 | ||
| Neuron-to-glia signaling mediated by excitatory amino acid receptors regulates ErbB receptor function in astroglial cells of the neuroendocrine brain | Q28582971 | ||
| Evaluation of Pax6 mutant rat as a model for autism | Q28941192 | ||
| A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function | Q29547320 | ||
| Spatio-temporal transcriptome of the human brain | Q29614572 | ||
| Personal genomes: The case of the missing heritability | Q29614582 | ||
| Dendritic spine pathology in neuropsychiatric disorders | Q29615871 | ||
| Astrocytes, from brain glue to communication elements: the revolution continues | Q29619493 | ||
| SCAP is required for timely and proper myelin membrane synthesis | Q30492405 | ||
| The application of DTI to investigate white matter abnormalities in schizophrenia | Q31028621 | ||
| Plasticity of astrocytic coverage and glutamate transporter expression in adult mouse cortex | Q33260752 | ||
| GeneTools--application for functional annotation and statistical hypothesis testing | Q33261405 | ||
| The Stanford Microarray Database: implementation of new analysis tools and open source release of software | Q33267232 | ||
| Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia | Q33400596 | ||
| Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder | Q33470869 | ||
| Functional gene group analysis reveals a role of synaptic heterotrimeric G proteins in cognitive ability | Q33645949 | ||
| Glial cells generate neurons: the role of the transcription factor Pax6. | Q34118701 | ||
| Pathway analysis of genomic data: concepts, methods, and prospects for future development | Q34223263 | ||
| Unique inflammatory RNA profiles of microglia in Creutzfeldt-Jakob disease | Q34470500 | ||
| Oxidative stress in schizophrenia: An integrated approach | Q34494844 | ||
| Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models | Q34560712 | ||
| Bombesin receptors as a novel anti-anxiety therapeutic target: BB1 receptor actions on anxiety through alterations of serotonin activity. | Q34571711 | ||
| Towards resolving the transcription factor network controlling myelin gene expression | Q35259052 | ||
| Microarrays and expression profiling in microglia research and in inflammatory brain disorders | Q36158202 | ||
| Functional gene group analysis identifies synaptic gene groups as risk factor for schizophrenia. | Q36253911 | ||
| White matter in learning, cognition and psychiatric disorders | Q36793946 | ||
| Pathway analysis of seven common diseases assessed by genome-wide association | Q37014849 | ||
| N-Cadherin and integrins: two receptor systems that mediate neuronal process outgrowth on astrocyte surfaces | Q37055884 | ||
| Regulation of secretory vesicle traffic by Rab small GTPases | Q37251862 | ||
| SNARE proteins and schizophrenia: linking synaptic and neurodevelopmental hypotheses. | Q37317830 | ||
| Bidirectional modulation of synaptic functions by Eph/ephrin signaling. | Q37333581 | ||
| Functional organization of the transcriptome in human brain | Q37373520 | ||
| Disturbed synaptic connectivity in schizophrenia: convergence of genetic risk factors during neurodevelopment | Q37740262 | ||
| Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia | Q37800531 | ||
| Changing face of microglia | Q37807203 | ||
| Regulation of synaptic connectivity by glia | Q37808619 | ||
| Gliotransmission and the tripartite synapse | Q37986663 | ||
| Roles of glial cells in schizophrenia: possible targets for therapeutic approaches | Q38059344 | ||
| DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. | Q38325560 | ||
| Cognitive dysfunction and glutamate reuptake: effect of EAAT2 polymorphism in schizophrenia | Q39597592 | ||
| Symptoms, signs, and diagnosis of schizophrenia | Q40461247 | ||
| Endothelins negatively regulate glial glutamate transporter expression. | Q42471954 | ||
| Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility | Q42649179 | ||
| Schizophrenia: a genetic disorder of the synapse? | Q42728470 | ||
| PKC signaling mediates global enhancement of excitatory synaptogenesis in neurons triggered by local contact with astrocytes | Q44758004 | ||
| Endothelins regulate astrocyte gap junctions in rat hippocampal slices | Q44791936 | ||
| Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples | Q46308032 | ||
| Sizing up human height variation | Q47235956 | ||
| TGFβ directs gene expression of activated microglia to an anti‐inflammatory phenotype strongly focusing on chemokine genes and cell migratory genes | Q47399868 | ||
| Genomic and proteomic microglial profiling: pathways for neuroprotective inflammatory responses following nerve fragment clearance and activation | Q48198684 | ||
| Rab4 and Rab5 GTPase are required for directional mobility of endocytic vesicles in astrocytes | Q48691767 | ||
| Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. | Q53411974 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 925-935 | |
| P577 | publication date | 2013-08-16 | |
| P1433 | published in | Schizophrenia Bulletin | Q4049133 |
| P1476 | title | Specific glial functions contribute to schizophrenia susceptibility | |
| P478 | volume | 40 |
| Q50015658 | A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia. |
| Q91530003 | Aberrant myelination of the cingulum and Schneiderian delusions in schizophrenia: a 7T magnetization transfer study |
| Q35034774 | Aggrecan and chondroitin-6-sulfate abnormalities in schizophrenia and bipolar disorder: a postmortem study on the amygdala |
| Q48029764 | Bad wrap: Myelin and myelin plasticity in health and disease |
| Q38281865 | Behavioral sequelae of astrocyte dysfunction: focus on animal models of schizophrenia. |
| Q47231098 | Candidate CSPG4 mutations and induced pluripotent stem cell modeling implicate oligodendrocyte progenitor cell dysfunction in familial schizophrenia. |
| Q47824709 | Cannabinoids and glial cells: possible mechanism to understand schizophrenia. |
| Q41290333 | Cell Type-Specific Effects of Mutant DISC1: A Proteomics Study |
| Q36539354 | Do glia drive synaptic and cognitive impairment in disease? |
| Q93047581 | Dysregulated Glial Differentiation in Schizophrenia May Be Relieved by Suppression of SMAD4- and REST-Dependent Signaling |
| Q50419804 | Dysregulation of miRNA and its potential therapeutic application in schizophrenia. |
| Q93164464 | Effects on Glial Cell Glycolysis in Schizophrenia: An Advanced Aging Phenotype? |
| Q36579965 | Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction |
| Q42204413 | Ephrin/Ephrin receptor expression in ammonia-treated rat astrocytes and in human cerebral cortex in hepatic encephalopathy |
| Q28067617 | From Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids Metabolism |
| Q41771732 | Functional gene-set analysis does not support a major role for synaptic function in attention deficit/hyperactivity disorder (ADHD). |
| Q99605075 | Genetic Variation in CNS Myelination and Functional Brain Connectivity in Recombinant Inbred Mice |
| Q59812978 | Genetic and Epigenetic Alterations Underlie Oligodendroglia Susceptibility and White Matter Etiology in Psychiatric Disorders |
| Q58462175 | Genetic identification of brain cell types underlying schizophrenia |
| Q56888533 | Genetic variation in 117 myelination-related genes in schizophrenia: Replication of association to lipid biosynthesis genes |
| Q39036735 | Genome-wide analysis of blood gene expression in migraine implicates immune-inflammatory pathways |
| Q38373219 | Glia-related genes and their contribution to schizophrenia |
| Q38845041 | Glial biomarkers in human central nervous system disease |
| Q52141970 | Increased MRI-based cortical grey/white-matter contrast in sensory and motor regions in schizophrenia and bipolar disorder. |
| Q52150395 | Increased density of DISC1-immunoreactive oligodendroglial cells in fronto-parietal white matter of patients with paranoid schizophrenia. |
| Q40232474 | Involvement of astrocyte and oligodendrocyte gene sets in migraine |
| Q36184543 | Involvement of astrocyte metabolic coupling in Tourette syndrome pathogenesis |
| Q38259759 | Maternal immune activation and abnormal brain development across CNS disorders. |
| Q37199033 | Modeling psychiatric disorders: from genomic findings to cellular phenotypes |
| Q30383611 | Molecular substrates of schizophrenia: homeostatic signaling to connectivity |
| Q33629435 | Myelination of parvalbumin interneurons: a parsimonious locus of pathophysiological convergence in schizophrenia |
| Q36591201 | Myelination-related genes are associated with decreased white matter integrity in schizophrenia |
| Q57800211 | Oligodendrocyte differentiation of induced pluripotent stem cells derived from subjects with schizophrenias implicate abnormalities in development |
| Q35107323 | Pathway analyses implicate glial cells in schizophrenia |
| Q38331188 | Physiological and pathophysiological functions of cell cycle proteins in post-mitotic neurons: implications for Alzheimer's disease |
| Q58549228 | Preterm Birth and the Risk of Neurodevelopmental Disorders - Is There a Role for Epigenetic Dysregulation? |
| Q47104449 | Prospects for Modeling Abnormal Neuronal Function in Schizophrenia Using Human Induced Pluripotent Stem Cells |
| Q48646111 | Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia |
| Q92070536 | Proteomics in Schizophrenia: A Gateway to Discover Potential Biomarkers of Psychoneuroimmune Pathways |
| Q89820100 | Quetiapine Modulates Histone Methylation Status in Oligodendroglia and Rescues Adolescent Behavioral Alterations of Socially Isolated Mice |
| Q38649490 | Rare genetic variants in CX3CR1 and their contribution to the increased risk of schizophrenia and autism spectrum disorders. |
| Q38183367 | Schizophrenia: susceptibility genes and oligodendroglial and myelin related abnormalities |
| Q35154276 | Specific binding and characteristics of 18β-glycyrrhetinic acid in rat brain |
| Q35860674 | Strain Differences in Presynaptic Function: PROTEOMICS, ULTRASTRUCTURE, AND PHYSIOLOGY OF HIPPOCAMPAL SYNAPSES IN DBA/2J AND C57Bl/6J MICE |
| Q47394958 | Subchronic olanzapine exposure leads to increased expression of myelination-related genes in rat fronto-medial cortex. |
| Q47875785 | The Importance of Non-neuronal Cell Types in hiPSC-Based Disease Modeling and Drug Screening |
| Q41535826 | The neurobiology of transition to psychosis: clearing the cache. |
| Q41362964 | Time-dependent changes in the mouse hippocampal synaptic membrane proteome after contextual fear conditioning |
| Q60045096 | Ultrastructural pathology of oligodendrocytes adjacent to microglia in prefrontal white matter in schizophrenia |
Search more.